Prevalence of Adverse Events of Pneumococcal and Influenza Vaccines among People with Diabetes

Author:

Shankar Arun1,Kesavadev Jothydev1,David Ashwin2,Ashik Asha3,Unes Yaseen4,Naina Junaid1,Krishnan Gopika1,Chandran Vysakh1,Jothydev Sunitha1

Affiliation:

1. Jothydev’s Diabetes Research Centre, Thiruvananthapuram, Kerala, India

2. Jothydev’s Diabetes Research Centre, Attingal, Kerala, India

3. Jothydev’s Diabetes Research Centre, Kochi, Kerala, India

4. Jothydev’s Diabetes Research Centre, Haripad, Kerala, India

Abstract

Abstract Background: People with diabetes have an increased risk of contracting influenza and pneumonia compared to healthy individuals. In addition, people with diabetes often have comorbidities that increase this risk. Vaccinations are an effective prophylaxis against these infections. The overall vaccination status is still low due to the fear of adverse events. Hence, it is important to analyze the risk of adverse vaccination events. The study aims to find the adverse events and tolerance of influenza and pneumococcal vaccines among people with diabetes who visited a tertiary diabetes care center. Methods: The study is a retrospective analysis of 5423 people with diabetes who received routine influenza and pneumococcal vaccinations. Postvaccination adverse events were collected from Diabetes Tele Management System®. Analysis was carried out using R program version 4.3.2 at a level of significance of 5%. Results: Among 5423 study participants, 2459 (45.34%) received the pneumococcal vaccine, while 2964 (54.65%) received the influenza vaccine. The majority of vaccine recipients, 3591 (66.21%), were male. Among the 2459 people who received the pneumococcal vaccine, 3.17% reported adverse events. Among the influenza group, 8.22% of people reported adverse events. Common adverse events experienced by the pneumococcal group included body pain, fever, tiredness, and pain at the injection site. The influenza group experienced cough, throat pain, sneezing, and asthma. These adverse events were treatable and self-limiting. Conclusion: The pneumococcal and influenza vaccinations were well tolerated by people with diabetes. A very small population reported adverse events, which were self-limiting, and treatable, resulting in a rapid recovery. Vaccinations are, therefore, highly recommended among people with diabetes and must be a part of their routine diabetes care. Vaccination is important to prevent infections and their complications.

Publisher

Medknow

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Vaccination in Diabetes: Updated Guidelines for 2024;International Journal of Diabetes and Technology;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3